您当前的位置:
首页 >
文章列表页 >
LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer
Short communication | 更新时间:2022-06-24
    • LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer

    • LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer

    • Genes & Diseases   2022年9卷第4期
    • 作者机构:

      1. Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University,Shanghai,PR China,200127

      2. Department of General Surgery, Beijing Friendship Hospital, Capital Medical University,Beijing,PR China,100050

    • DOI:10.1016/j.gendis.2021.10.001    

      中图分类号:
    • 纸质出版日期:2022,

      网络出版日期:2022-7-1,

    扫 描 看 全 文

  • Yaqian Xu, Chenwei Yuan, Jing Peng, 等. LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer[J]. Genes & Diseases, 2022,9(4). DOI: 10.1016/j.gendis.2021.10.001.

    Yaqian Xu, Chenwei Yuan, Jing Peng, et al. LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer[J]. Genes & Diseases, 2022,9(4). DOI: 10.1016/j.gendis.2021.10.001.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据
0